Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander T Cohen

Showing results (31-40 of 227) with videos related to

Pageof 23
Sort By:
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 2, 2005
Pharmacological prevention of venous thromboembolism in medical patients at riskMia Wolozinsky, Yshai Y Yavin, Alexander T Cohen
The New England Journal of Medicine|May 17, 2013
Rivaroxaban for thromboprophylaxis in acutely ill medical patientsAlexander T Cohen, Theodore E Spiro, Alex C Spyropoulos, et al.
Thrombosis Research|June 12, 2012
Thromboprophylaxis in non-surgical cancer patientsAlexander T Cohen, Meredith M P Gurwith, Mark Dobromirski
British Journal of Haematology|January 31, 2020
Prediction of significant bleeding during vitamin K antagonist treatment for venous thromboembolism in outpatientsCarlos Martinez, Anja Katholing, Christopher Wallenhorst, et al.
Thrombosis Research|November 5, 2013
Managing pulmonary embolism from presentation to extended treatmentAlexander T Cohen, Mark Dobromirski, Meredith M P Gurwith
The New England Journal of Medicine|December 16, 2016
Betrixaban in Acutely Ill Medical PatientsAlexander T Cohen, Robert A Harrington, C Michael Gibson
Haematologica|April 17, 2025
Response to Comment on: "Targeted anti-cancer agents and risk of venous thromboembolism"Melina Verso, Florian Moik, Mara Graziani, et al.
Seminars in Respiratory and Critical Care Medicine|February 17, 2017
The Novel Oral Anticoagulants for Acute Venous Thromboembolism: Is Warfarin Dead?Alexander T Cohen, Serena Granziera, Nicola Veronese, et al.
Haematologica|December 2, 2024
Targeted anti-cancer agents and risk of venous thromboembolismMelina Verso, Florian Moik, Mara Graziani, et al.
Thrombosis Research|May 4, 2010
VTE prophylaxis for the medical patient: where do we stand? - a focus on cancer patientsAlexander T Cohen, Bharathi Nandini, Jack O Wills, et al.
Pageof 23

Showing results (31-40 of 227) with videos related to

Sort By:
Pageof 23
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 2, 2005
Pharmacological prevention of venous thromboembolism in medical patients at riskMia Wolozinsky, Yshai Y Yavin, Alexander T Cohen
The New England Journal of Medicine|May 17, 2013
Rivaroxaban for thromboprophylaxis in acutely ill medical patientsAlexander T Cohen, Theodore E Spiro, Alex C Spyropoulos, et al.
Thrombosis Research|June 12, 2012
Thromboprophylaxis in non-surgical cancer patientsAlexander T Cohen, Meredith M P Gurwith, Mark Dobromirski
British Journal of Haematology|January 31, 2020
Prediction of significant bleeding during vitamin K antagonist treatment for venous thromboembolism in outpatientsCarlos Martinez, Anja Katholing, Christopher Wallenhorst, et al.
Thrombosis Research|November 5, 2013
Managing pulmonary embolism from presentation to extended treatmentAlexander T Cohen, Mark Dobromirski, Meredith M P Gurwith
The New England Journal of Medicine|December 16, 2016
Betrixaban in Acutely Ill Medical PatientsAlexander T Cohen, Robert A Harrington, C Michael Gibson
Haematologica|April 17, 2025
Response to Comment on: "Targeted anti-cancer agents and risk of venous thromboembolism"Melina Verso, Florian Moik, Mara Graziani, et al.
Seminars in Respiratory and Critical Care Medicine|February 17, 2017
The Novel Oral Anticoagulants for Acute Venous Thromboembolism: Is Warfarin Dead?Alexander T Cohen, Serena Granziera, Nicola Veronese, et al.
Haematologica|December 2, 2024
Targeted anti-cancer agents and risk of venous thromboembolismMelina Verso, Florian Moik, Mara Graziani, et al.
Thrombosis Research|May 4, 2010
VTE prophylaxis for the medical patient: where do we stand? - a focus on cancer patientsAlexander T Cohen, Bharathi Nandini, Jack O Wills, et al.
Pageof 23